Concepedia

Nzeera Ketter

NK

26

Publications

3.8K

Citations

22

H-Index

1991

Active since

Affiliations

Janssen (United States)(Current)

Johnson & Johnson (United States)

Pfizer (United States)

International AIDS Vaccine Initiative

National Institute of Allergy and Infectious Diseases

Nzeera Ketter is an author at Janssen (United States) specializing in medicine, immunology, and vaccination.

Top concepts

Publications per year

1991–2019

26

Publications

26

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection

Jeffrey M. Jacobson, John S. Greenspan, John Spritzler et al. · New England Journal of Medicine · 1997 · 422 citations · Full text

A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection

Robert R. Redfield, Deborah L. Birx, Nzeera Ketter et al. · New England Journal of Medicine · 1991 · 245 citations · Full text

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa

Etienne Karita, Nzeera Ketter, Matt A. Price et al. · PLoS ONE · 2009 · 165 citations · Full text

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

Álvaro Réa-Neto, Michael S. Niederman, Suzana Margareth Lobo et al. · Current Medical Research and Opinion · 2008 · 119 citations

Rows per page

1–5 of 26